http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102172700-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
filingDate 2013-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102172700-B1
titleOfInvention Preparation of intermediates of x-ray contrast agents
abstract The present invention relates to a process for the preparation of iodinated X-ray contrast agents, in particular their core intermediates. The present invention particularly relates to an intermediate in the industrial production of non-ionic X-ray contrast agents, 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- Triiodoisophthalamide (Compound A) or N,N'-bis(2,3-dihydroxypropyl)-5-formamido-2,4,6-triiodoisophthalamide (Compound C) It relates to an improved manufacturing method of. More specifically, the present invention provides a method for deacylating the acylated hydroxyl groups of the intermediate compounds of these compounds A and C.
priorityDate 2012-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431407178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413669495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25222171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11115326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86649138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412301145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414894054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90134251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424885426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528350

Total number of triples: 47.